The immunostimulatory peptide WKYMVm-NH2 activates bone marrow mouse neutrophils via multiple signal transduction pathways

Scandinavian Journal of Immunology

Volumn 62, Issue 2, 2005, Pages 140-147

  Boxio, R ^a   Bossenmeyer Pourie C ^a   Vanderesse, R ^a   Dournon, C ^a   Nüße, Oliver ^b,c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 MORPHOLINO 8 PHENYLCHROMONE; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEPTIDE ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; STAUROSPORINE; SUPEROXIDE; THAPSIGARGIN; TRYPTOPHYLLYSYLTYROSYLMETHIONYLVALYL DEXTRO METHIONINAMIDE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSTIMULATION; INNATE IMMUNITY; MOUSE; NEUTROPHIL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANDROSTADIENES; ANIMALS; BONE MARROW CELLS; CHROMONES; ENZYME INHIBITORS; GLUCURONIDASE; LACTOFERRIN; MICE; MICE, INBRED C57BL; MORPHOLINES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; OLIGOPEPTIDES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 23844500010     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01651.x     Document Type: Article

References (29)

1. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002;23:541-8.
2. 2+ concentrations are essential and synergize with a kinetically distinct second signal. Biochem J 1997;322:709-18.
3. 2+ influx and stimulation of exocytosis in HL-60 granulocytes. J Biol Chem 1997;272:28360-7.
4. Back SH, Seo JK, Chae CB, Suh PG, Ryu SH. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 1996;271:8170-5.
5. Bae YS, Kim Y, Kim Y, Kim JH, Suh PG, Ryu SH. Trp-Lys-Tyr-Met-Val-D-Met is a chemoattractant for human phagocytic cells. J Leukoc Biol 1999;66:915-22.
6. Seo JK, Choi SY, Kim Y et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol 1997;158:1895-901.
7. Christophe T, Karlsson A, Rabiet MJ, Boulay F, Dahlgren C. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Scand J Immunol 2002;56:470-6.
8. Le Y, Oppenheim JJ, Wang JM. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev 2001;12:91-105.
9. Boulay F, Tardif M, Brouchon L, Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990;29:11123-33.
10. Wang ZG, Ye RD. Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. Gene 2002;299:57-63.
11. Gao JL, Lee EJ, Murphy PM. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 1999;189:657-62.
12. Bylund J, Samuelsson M, Collins LV, Karlsson A. NADPH-oxidase activation in murine neutrophils via formyl peptide receptors. Exp Cell Res 2003;282:70-7.
13. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nüße O. Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 2004;75:604-11.
14. Neimark J, Briand JP. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept Res 1993;6:219-28.
15. Mocsai A, Ligeti E, Lowell CA, Berton G. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J Immunol 1999;162:1120-6.
16. Svensson L, Dahlgren C, Wenneras C. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. J Leukoc Biol 2002;72:810-8.
17. Tuluc F, Meshki J, Kunapuli SP. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils. Int Immunopharmacol 2003;3:1775-90.
18. Gewirtz AT, Fokin W, Petasis NA, Serhan CN, Madara JL. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am J Physiol 1999;276:C988-94.
19. Dewald B, Thelen M, Baggiolini M. Two transduction sequences are necessary for neutrophil activation by receptor agonists. J Biol Chem 1988;263:16179-84.
20. Borregaard N, Lollike K, Kjeldsen L et al. Human neutrophil granules and secretory vesicles. Eur J Haematol 1993;51:187-98.
21. 3+-sensitive pathway and is a partial secretagogue: involvement of pertussis-toxin-sensitive G-proteins and protein phosphatases 1/2A and 2B in the signal-transduction pathway. Biochem J 1996;314:679-86.
22. + influx channels in leukocytes: a therapeutic target? Trends Pharmacol Sci 2002;23:63-70.
23. Lavigne MC, Murphy PM, Leto TL, Gao JL. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils. Cell Immunol 2002;218:7-12.
24. Bae YS, Yi HJ, Lee HY et al. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J Immunol 2003;171:6807-13.
25. Bae YS, Song JY, Kim Y et al. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol Pharmacol 2003;64:841-7.
26. 2 or lipoxin A4 in human neutrophils. Mol Pharmacol 2003;64:721-30.
27. Dahlgren C, Christophe T, Boulay F, Madianos PN, Rabiet MJ, Karlsson A. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 2000;95:1810-8.
28. Bae YS, Lee HY, Jo EJ et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 2004;173:607-14.
29. Matthews T, Salgo M, Greenberg M, Chung J, DeMasi R, Bolognesi D. Enfuvirtide. the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Nat Rev Drug Discov 2004;3:215-25.